T1	Participants 56 111	patients affected by acne and polycystic ovary syndrome
T2	Participants 313 343	few patients, especially women
T3	Participants 506 572	women with acne and proven PCOS therapy with estroprogestins (EPs)
T4	Participants 970 986	Fifty-nine women
